These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8395437)

  • 1. Long-term effects of alpha-interferon for treatment of chronic hepatitis C in terms of histological changes with aminotransferase normalization and hepatitis C virus RNA seroconversion.
    Hosoda K; Yokosuka O; Kato N; Ito Y; Ohto M; Omata M
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():115-7. PubMed ID: 8395437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.
    Kakumu S; Yoshika K; Tanaka K; Higashi Y; Kurokawa S; Hirofuji H; Kusakabe A
    J Med Virol; 1993 Sep; 41(1):65-70. PubMed ID: 8228941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognosis of chronic hepatitis C after treatment with interferon alpha 2b and characterization of incomplete responders.
    Hakozaki Y; Shirahama T; Katou M; Nakagawa K; Oba K; Yoshii O; Matsumoto T; Kuwabara N; Mitamura K
    Am J Gastroenterol; 1996 Oct; 91(10):2144-9. PubMed ID: 8855738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course.
    Reichard O; Glaumann H; Norkrans G; Wejstål R; Fryden A; Schvarcz R; Weiland O
    Liver; 1994 Aug; 14(4):169-74. PubMed ID: 7526108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation.
    Wright TL; Combs C; Kim M; Ferrell L; Bacchetti P; Ascher N; Roberts J; Wilber J; Sheridan P; Urdea M
    Hepatology; 1994 Oct; 20(4 Pt 1):773-9. PubMed ID: 7927216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.
    Aiyama T; Yoshioka K; Hirofuji H; Kusakabe A; Yamada M; Tanaka K; Kakumu S
    Dig Dis Sci; 1994 Oct; 39(10):2244-9. PubMed ID: 7924750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
    Kusaka S; Okusa T; Araki A; Fujiki K; Takashimizu I; Okayasu I; Yamamoto N; Sato C
    J Med Virol; 1995 Jul; 46(3):265-8. PubMed ID: 7561801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.
    Orito E; Mizokami M; Suzuki K; Ohba KI; Ohno T; Mizuno M; Iijima Y; Saito H; Nemoto A; Nukuta N
    J Gastroenterol Hepatol; 1997 Jan; 12(1):58-61. PubMed ID: 9076625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon treatment for chronic hepatitis C infection in hemophiliacs--influence of virus load, genotype, and liver pathology on response.
    Hanley JP; Jarvis LM; Andrew J; Dennis R; Hayes PC; Piris J; Lee R; Simmonds P; Ludlam CA
    Blood; 1996 Mar; 87(5):1704-9. PubMed ID: 8634415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.
    Hino K; Sainokami S; Shimoda K; Iino S; Wang Y; Okamoto H; Miyakawa Y; Mayumi M
    J Med Virol; 1994 Mar; 42(3):299-305. PubMed ID: 7516422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.
    Lau DT; Kleiner DE; Ghany MG; Park Y; Schmid P; Hoofnagle JH
    Hepatology; 1998 Oct; 28(4):1121-7. PubMed ID: 9755252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.
    Mizokami M; Orito E; Gibo Y; Suzuki K; Ohba K; Ohno T; Lau JY
    Liver; 1996 Feb; 16(1):23-7. PubMed ID: 8868074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha.
    Carreño V; Tapia L; Ryff JC; Quiroga JA; Castillo I
    J Med Virol; 1992 Jul; 37(3):215-9. PubMed ID: 1331310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon retreatment of nonresponders with HCV-RNA-positive chronic hepatitis C.
    Arase Y; Kumada H; Chayama K; Tsubota A; Koida I; Ikeda K; Saitoh S; Matsumoto T; Kobayashi M
    J Gastroenterol; 1994 Jun; 29(3):299-304. PubMed ID: 8061799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C.
    Shindo M; Arai K; Okuno T
    J Hepatol; 1997 Mar; 26(3):492-7. PubMed ID: 9075654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term histological outcome in patients with chronic hepatitis C treated repeatedly with interferon alpha-2b without sustained response.
    Reichard O; Glaumann H; Weiland O
    Scand J Infect Dis; 1994; 26(4):383-9. PubMed ID: 7984968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs.
    Makris M; Preston FE; Triger DR; Underwood JC; Westlake L; Adelman MI
    Blood; 1991 Oct; 78(7):1672-7. PubMed ID: 1912556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
    Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
    Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.
    Shiffman ML; Hofmann CM; Thompson EB; Ferreira-Gonzalez A; Contos MJ; Koshy A; Luketic VA; Sanyal AJ; Mills AS; Garrett CT
    Hepatology; 1997 Sep; 26(3):780-5. PubMed ID: 9303513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.